Comparison of renal safety and bone mineral density of tenofovir and entecavir in patients with chronic hepatitis B: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Comparison of renal safety and bone mineral density of tenofovir and entecavir in patients with chronic hepatitis B: a systematic review and meta-analysis

Published:2022-11 Issue: Volume:124 Page:133-142
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Yang Xiaoxian,Yan Haiyi,Zhang Xiuju,Qin Xueying,Guo Peng

Funder

National Natural Science Foundation of China

China Academy of Chinese Medical Sciences

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference30 articles.

1. Bone mineral density and renal function in chronic hepatitis B patients receiving nucleotide versus nucleoside analogs: a pilot prospective study;Bunchorntavakul;J Med Assoc Thai,2016

2. Renal function in nucleos(t)ide analog-treated patients with chronic hepatitis B: a systematic literature review and network meta-analysis;Chan;Adv Ther,2016

3. Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: a multicenter study;Chon;J Viral Hepat,2022

4. Bone loss in hepatitis B virus-infected patients can be associated with greater osteoclastic activity independently of the retroviral use;Dessordi;Sci Rep,2021

5. Side effects of long-term oral antiviral therapy for hepatitis B;Fontana;Hepatology,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Pharmacokinetics of a BCS Class III Drug with Two Different Study Designs: Tenofovir Alafenamide Monofumarate Film-coated Tablet;AAPS PharmSciTech;2024-05-30

2. Renal dysfunction during treatment of chronic hepatitis B with tenofovir disoproxyl fumarate and associated risk factors;European Journal of Gastroenterology & Hepatology;2024-02-23

3. Association of chronic liver disease with bone diseases and muscle weakness;Journal of Bone and Mineral Metabolism;2024-02-01

4. Efficacy and safety of tenofovir disoproxil fumarate versus entecavir in the treatment of acute-on-chronic liver failure with hepatitis B: a systematic review and meta-analysis;BMC Gastroenterology;2023-11-13

5. The Effect of Entecavir and Tenofovir Disoproxil on Bone Mineral Density in Chronic Hepatitis B Treatment;Journal of Contemporary Medicine;2023-09-30